Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex.
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
Possible pathogenic engagement of soluble Semaphorin 4D produced by γδT cells in medication-related osteonecrosis of the jaw (MRONJ).
[Vitamin D for prevention of diseases?].
The impact of environmental infections (parasites) on MS activity.
Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross-sectional study.
Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
Nerve Conduction Velocity Is Regulated by the Inositol Polyphosphate-4-Phosphatase II Gene.
Excess of melanocytic nevi in a patient treated with natalizumab for multiple sclerosis.
Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry.
Lessons from Jack Griffin and the "pathogenesis of peripheral nerve disease".
1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.
Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.
Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis
Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Olive oil phenols and neuroprotection.
An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β.
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
Investigating Axonal Damage in Multiple Sclerosis by Diffusion Tensor Spectroscopy.
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.

Pages